tyrphostin ag 1024 has been researched along with Cell Transformation, Neoplastic in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 2 |
| Chen, N | 1 |
| Xu, H | 1 |
| Wang, J | 1 |
| Fang, X | 1 |
| Zhang, Y | 1 |
| Li, Y | 1 |
| Yang, J | 1 |
| Wang, X | 1 |
1 other study available for tyrphostin ag 1024 and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Topics: Adaptor Proteins, Signal Transducing; Aged; Animals; Apoptosis; B-Lymphocytes; Cell Cycle Checkpoint | 2020 |